Streetbeat News

Price Targets

BAC

JPM

MS

V

Analysts have provided updates on financial stocks Visa Inc. (V), JPMorgan Chase & Co. (JPM), Bank of America Corporation (BAC), and Morgan Stanley (MS). Coverage includes new ratings, price target changes, and recent news such as Visa's collaboration with International Money Express, JPMorgan's acquisition of a stake in Indra, and Bank of America's preferred stock dividends. Analysts' accuracy rates and expected stock movements are highlighted.

Portfolio Pulse from Avi Kapoor

December 27, 2023 | 1:13 pm

DOGEUSD

FLOKIUSD

Cryptocurrency analyst Crypto Tony predicts a rally for Dogecoin (DOGE) if it flips the resistance level of $0.106 into support, suggesting a potential 'Memeseason' with Dogecoin and Floki (FLOKI) leading the charge. The analyst also identified a resistance near $0.12 and a support level at $0.045. For FLOKI, a resistance level at $0.000060 was mentioned, indicating significant gains if breached. Currently, DOGE is trading at $0.091, down 1.72%.

Portfolio Pulse from Mehab Qureshi

December 27, 2023 | 1:00 pm

TSLA

Morgan Stanley analyst Adam Jonas has reiterated an Overweight rating on Tesla (NASDAQ:TSLA) and maintained a price target of $380.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 12:56 pm

ADBE

AMAT

AMZN

COIN

Notable insider sales were reported for Applied Materials, Adobe, Amazon, and Coinbase Global. Applied Materials' CTO sold shares worth $3.77 million, while Adobe's CEO and CFO sold shares totaling over $19 million. Amazon's CEO of AWS sold shares worth $153,515, and a Coinbase Global director sold shares worth $190,883. These sales could indicate various motivations, including personal financial management or views on the company's valuation. Additionally, Adobe and Figma terminated their $20 billion merger agreement, and JMP Securities raised its price target for Coinbase.

Portfolio Pulse from Avi Kapoor

December 27, 2023 | 12:54 pm

FUSN

Raymond James analyst Rahul Sarugaser has upgraded Fusion Pharmaceuticals (NASDAQ:FUSN) from Outperform to Strong Buy and increased the price target from $12 to $15.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 12:38 pm

ORGO

BTIG analyst Ryan Zimmerman has reaffirmed a Buy rating on Organogenesis Holdings (NASDAQ:ORGO) and increased the price target from $4 to $6.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 12:27 pm

ASPN

Canaccord Genuity analyst George Gianarikas has maintained a Buy rating on Aspen Aerogels (NYSE:ASPN) and increased the price target from $13 to $17, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 12:24 pm

PMVP

Ladenburg Thalmann analyst Aydin Huseynov has initiated coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and set a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 12:03 pm

EXPE

Expedia Group (NASDAQ:EXPE) received mixed analyst ratings over the past three months, with 7 analysts offering their perspectives. The average 12-month price target for EXPE has increased to $155.0, up from $130.43, with a high estimate of $200.00 and a low of $115.00. Analysts from firms including BTIG, Barclays, Oppenheimer, Evercore ISI Group, Morgan Stanley, Piper Sandler, and Wedbush have raised their price targets for EXPE. The company's financials show a market capitalization above industry average, a revenue growth rate of 8.57% as of September 30, 2023, but lagging net margin, ROE, and ROA compared to industry averages, and a debt-to-equity ratio of 3.91.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 12:00 pm

EXPE

BTIG analyst Jake Fuller has reaffirmed a Buy rating on Expedia Group (NASDAQ:EXPE) and increased the price target from $150 to $175, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 11:54 am